{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:48:56Z","timestamp":1766087336880},"reference-count":26,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2019,1,17]]},"abstract":"<jats:sec>\n<jats:title>Background: <\/jats:title>\n<jats:p>The clozapine-derivative quetiapine has been shown in some cases to cause leukopenia and neutropenia.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Case Presentation: <\/jats:title>\n<jats:p>We reported on a case of a young female diagnosed with treatment-resistant\nschizophrenia. After failed trials of three antipsychotic medications and despite a history of quetiapineinduced\nleukopenia, clozapine treatment was introduced due to the severity of the patient\u2019s symptoms,\nthe limited effective treatment options, and a lack of guidelines on this issue.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Result: <\/jats:title>\n<jats:p>Over a ten-week period of clozapine treatment at 700 mg per day, the patient developed\nagranulocytosis. Her white blood cell count sharply dropped to 1.6 &amp;#215; 10&lt;sup&gt;9&lt;\/sup&gt; L, and her neutrophils\ndecreased to 0.1 &amp;#215; 10&lt;sup&gt;9&lt;\/sup&gt; L. There had been no similar reaction to her previous medications\n(carbamazepine, risperidone, and haloperidol).\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion: <\/jats:title>\n<jats:p>The safety of clozapine in a patient who has previously experienced leukopenia and\nneutropenia with quetiapine requires further investigation. Increased attention should be paid to such\ncases. Careful monitoring and slow titration are advisable.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574886313666180807094654","type":"journal-article","created":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T00:38:57Z","timestamp":1535157537000},"page":"80-83","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Safety of a Clozapine Trial Following Quetiapine-Induced Leukopenia: A Case Report"],"prefix":"10.2174","volume":"14","author":[{"given":"Asma H.","family":"Almaghrebi","sequence":"first","affiliation":[{"name":"Saudi Commission for Health Specialties, Psychiatry Speciality, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","author":"Stephen S.S.","year":"2013","unstructured":"Stephen SS.","journal-title":"Essential psychopharmachology"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamapsychiatry.2015.2966","volume":"73","author":"Correll C.U.","year":"2016","unstructured":"Correll CU, Kane JM.  The role of clozapine in treatment-resistant schizophrenia.","journal-title":"JAMA Psychiatry"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/0706743716660710","volume":"62","author":"Kisely S.","year":"2017","unstructured":"Kisely S, Siskind D, Siskind V.  Clozapine response rates among people with treatment-resistant schizophrenia: Data from a systematic review and meta-analysis.","journal-title":"Can J Psychiatry"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1017\/S146114571100201X","volume":"15","author":"Dickens G.","year":"2012","unstructured":"Dickens G, Frogley C, Picchioni M, Taylor D.  A systematic review of the evidence of clozapine\u2019s anti-aggressive effects.","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archpsyc.60.7.735","volume":"60","author":"Alphs L.","year":"2003","unstructured":"Alphs L, Altamura C, Anand R.  Clozapine treatment for suicidality in schizophrenia.","journal-title":"Arch Gen Psychiatry"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamapsychiatry.2015.2955","volume":"73","author":"Dold M.","year":"2016","unstructured":"Dold M, Gianatsi M, Helfer B.  Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: A network meta-analysis.","journal-title":"JAMA Psychiatry"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hup.1181","volume":"26","author":"Carvalhoand F.","year":"2011","unstructured":"Carvalhoand F, Flanagan R, Nooijen P.  Haematological toxicity of clozapine and some other drugs used in psychiatry.","journal-title":"Hum Psychopharmacol Clin"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-2004-815513","volume":"37","author":"Bandelow B.","year":"2004","unstructured":"Bandelow B, Engel R, Grohmann R, Ludwig WD, St\u00fcbner S, Wagner G.  Blood dyscrasias induced by psychotropic drugs.","journal-title":"Pharmacopsychiatry"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4088\/JCP.11r06977","volume":"73","author":"Cohen D.","year":"2012","unstructured":"Cohen D, Bogers J, Van Dijk D, Bakker B, Schulte P.  Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy.","journal-title":"J Clin Psychiatry"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hup.917","volume":"23","author":"Dunk L.","year":"2008","unstructured":"Dunk L, Flanagan R.  Haematological toxicity of drugs used in psychiatry.","journal-title":"Hum Psychopharmacol Clin"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1089\/cap.2012.0092","volume":"23","author":"DelBello M.","year":"2013","unstructured":"DelBello M, Earley WR, Findling RL, Liu S, Pathak S.  Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: A 26-week, open-label, continuation study.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref=12","author":"","year":"","unstructured":".  Seroquel 25 mg, 100 mg, 200 mg and 300 mg film-coated tablets. From the electronic Medicines Compendium (eMC); Available from:"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1034\/j.1600-0447.2001.00429.x","volume":"104","author":"Becker H.E.","year":"2001","unstructured":"Becker HE, Heeringa M, Jessurun P, Marees CH, Ruh\u00e9 HG, Vermeulen HDB.  Agranulocytosis and granulocytopenia associated with quetiapine.","journal-title":"Acta Psychiatr Scand"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1192\/bjp.188.3.255","volume":"188","author":"Andrews C.D.","year":"2006","unstructured":"Andrews CD, Annan LJ, Dunk LR.  Rechallenge with clozapine following leucopenia or neutropenia during previous therapy.","journal-title":"Br J Psychiatry"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1021\/tx2005635","volume":"25","author":"Cameron M.D.","year":"2012","unstructured":"Cameron MD, Li X.  Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis.","journal-title":"Chem Res Toxicol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/eip.12134","volume":"9","author":"Cr\u00e9peau-Gendron G.","year":"2015","unstructured":"Cr\u00e9peau-Gendron G, L\u2019Heureux S.  Quetiapine XR-induced neutropenia: Is a clozapine trial still possible for treatment-resistant schizophrenia? A case report.","journal-title":"Early Interv Psychiatry"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pnpbp.2006.07.003","volume":"31","author":"Cowan C.","year":"2007","unstructured":"Cowan C, Oakley C.  Leukopenia and neutropenia induced by quetiapine.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=18","first-page":"307","volume":"59","author":"Arellano F.","year":"1998","unstructured":"Arellano F, Bianchini A, Honigfeld G, Schein J, Sethi J.  Reducing clozapine-related morbidity and mortality: 5 years of experience with the clozaril national registry.","journal-title":"J Clin Psychiatry"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1176\/appi.psy.42.4.368","volume":"41","author":"Croarkin P.","year":"2001","unstructured":"Croarkin P, Rayner T.  Acute neutropenia in a patient treated with quetiapine.","journal-title":"Psychosomatics"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.taap.2016.12.003","volume":"316","author":"Dettling M.","year":"2017","unstructured":"Dettling M, Hahn E, Herzog I.  Clozapine-induced agranulocytosis: Evidence for an immune-mediated mechanism from a patient-specific  approach.","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","volume":"329","author":"Alvir J.","year":"1993","unstructured":"Alvir J, Lieberman J, Safferman A, Schaaf J, Schwimmer J.  Clozapine-induced a granulocytosis: Incidence and risk factors in the United States.","journal-title":"N Engl J Med"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0010-440X(99)90134-7","volume":"40","author":"Barak Y.","year":"1999","unstructured":"Barak Y, Kutzuk D, Naor S, Weizman A, Wittenberg N.  Clozapine in elderly psychiatric patients: Tolerability, safety, and efficacy.","journal-title":"Compr Psychiatry"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/tpj.2017.6","volume":"17","author":"de With S.A.J.","year":"2017","unstructured":"de With SAJ, Kahn RS, Ophoff RA, Pulit SL, Staal WG.  More than 25 years of genetic studies of clozapine-induced agranulocytosis.","journal-title":"Pharmacogenomics J"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2217\/pgs.15.67","volume":"16","author":"Lewis C.M.","year":"2015","unstructured":"Lewis CM, Verbelen M.  How close are we to a pharmacogenomic test for clozapine-induced agranulocytosis?","journal-title":"Pharmacogenomics"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1038\/ncomms5757","volume":"5","author":"Alfirevic A.","year":"2014","unstructured":"Alfirevic A, Duncan L, Fourches D.  Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.","journal-title":"Nat Commun"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11920-011-0185-3","volume":"13","author":"Chowdhury N.","year":"2011","unstructured":"Chowdhury N, Kennedy J, Remington G.  Genetics of antipsychotic-induced side effects and agranulocytosis.","journal-title":"Curr Psychiatry Rep"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/164385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T14:59:22Z","timestamp":1555858762000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/164385\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,17]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886313666180807094654","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,17]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-06-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}